Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Therapy and Adipose Tissue Remodeling
NCT04387201Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- May 2020
- Primary completion
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dulaglutide biosimilar 14028 injection in prediabetes, sponsored by UTHealth Houston. Started May 2020; status: completed.
02
Drugs
dulaglutide biosimilar 14028 injection
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT04387201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387201.